CORONAVIRUS/Antibody therapy for COVID-19 shows promise in animal tests: NHRI

07/29/2020 08:53 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, July 29 (CNA) A monoclonal antibody (mAb) treatment being developed by Taiwan's National Health Research Institutes (NHRI) has been shown to significantly reduce levels of the COVID-19 coronavirus in infected animals, the body's leading infectious disease official said Wednesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.